| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Dec―08 |
Model-informed repurposing of pyronaridine for mild to moderate COVID-19: predicting target organ exposure and therapeutic potential |
Dong Wook Kang, Ju Hee Kim, Hea-Young Cho |
| 2 |
[GO] |
2022―Oct―26 |
COVID-19 drugs: potential interaction with ATP-binding cassette transporters P-glycoprotein and breast cancer resistance protein |
Jaeok Lee, Jihye Kim, Jiyeon Kang, Hwa Jeong Lee |
| 3 |
[GO] |
2021―Sep―06 |
Nanoparticles of ZnO/Berberine complex contract COVID-19 and respiratory co-bacterial infection in addition to elimination of hydroxychloroquine toxicity |
Doaa A. Ghareeb, Samar R. Saleh, Mohamed G. Seadawy, Mohammed S. Nofal, Shaymaa A. Abdulmalek, Salma F. Hassan, et al. (+17) Shaimaa M. Khedr, Miral G. AbdElwahab, Ahmed A. Sobhy, Ali saber Ali Abdel-Hamid, Abdelrahman Mohamed Yassin, Alshimaa A. Abd Elmoneam, Aliaa A. Masoud, Mohamed M. Y. Kaddah, Sally A. El-Zahaby, Abdulaziz Mohsen Al-mahallawi, Alaa M. El-Gharbawy, Ahmed Zaki, Inas k. Seif, Marwa Y. Kenawy, Magdy Amin, Khaled Amer, Maha Adel El Demellawy |
| 4 |
[GO] |
2021―Mar―05 |
Potential therapeutic and pharmacological strategies for SARS-CoV2 |
Doaa A. Ghareeb, Samar R. Saleh, Mohammed S. Nofal, Mohamed M. Y. Kaddah, Salma. F. Hassan, Inas K. Seif, et al. (+11) Sally A. El-Zahaby, Shaimaa M. Khedr, Marwa Y. Kenawy, Aliaa A. Masoud, Salma A. Soudi, Ahmed A. Sobhy, Jaillan G. Sery, Miral G. Abd El-Wahab, Alshimaa A. Abd Elmoneam, Abdulaziz Mohsen Al-mahallawi, Maha A. El-Demellawy |
|
